arrow
F

Francisco J. Blanco

complexo hospitalario universitario de a coruna
H指数:83
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vasoactive intestinal peptide advances chondrogenesis and modulates pathogenic mediators in human osteoarthritis

血管活性肠肽促进软骨形成并调节人类骨关节炎中的致病介质

2026-05-250
PRE
Uncovering the Impact of Center of Rotation of Angulation Location on High Tibial Osteotomy in Knee Osteoarthritis: A Potential Pathway for Improved Outcomes

揭示外翻角中心旋转位置对膝关节骨性关节炎高位胫骨截骨术影响:改善预后的潜在途径

2026-02-180
PRE
Clinical and molecular data to predict flares in DMARD optimization in rheumatoid arthritis: a randomised, controlled, open-label, non-inferiority trial
2026-01-240
OA
How are patient-reported pain outcomes associated with biomarker and structural pathology subtypes in knee osteoarthritis? An explorative evaluation in the IMI-APPROACH cohort

患者报告的疼痛结局与生物标志物和结构病理亚型在膝关节骨关节炎中的关联如何?一项在IMI-APPROACH队列中的探索性评估

2025-12-010
OAAI
Unicompartmental versus Bicompartmental Joint Space Width measures: Which Reflect Whole Joint Structural Damage Better? Data From IMI-APPROACH

单间室与双间室关节间隙宽度测量:哪种更能反映整体关节结构性损伤?数据来自IMI-APPROACH

2025-11-280
OAAI
Do rates of femorotibial cartilage loss in Kellgren-Lawrence 2 and 3 knees differ between those with mild-moderate vs. severe patellofemoral structural damage? – Data from the FNIH and IMI-APPROACH cohorts

Kellgren-Lawrence 2级和3级膝关节的股胫软骨丢失率,在轻度至中度与重度髌股结构损伤患者之间是否存在差异?——数据来自FNIH和IMI-APPROACH队列研究

2025-10-120
OAAI
Fluctuation of Bone Marrow Lesions and Inflammatory MRI Markers over 2 Years and Concurrent Associations with Quantitative Cartilage Loss

2年内骨髓病变和炎症性MRI标记物的波动及其与定量软骨损失的同时关联

2024-10-260
PRE
Bacteriuria and phenotypic antimicrobial susceptibility testing in 45 min by point-of-care Sysmex PA-100 System: first clinical evaluation

通过Sysmex PA-100系统在45分钟内进行菌尿和表型抗生素敏感性测试: 首次临床评估

2024-06-035
OAAI
SINGLE CELL RNA-SEQ CHARACTERIZATION OF CIRCULATING IMMUNE CELLS IN SJOGREN'S SYNDROME: COMPARISON TO SLE AND RHEUMATOID ARHTRITIS

单细胞RNA测序分析干燥综合征外周血循环免疫细胞特征:与SLE和类风湿关节炎的比较

2024-06-010
PRE